CENTENE CORPORATION Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
CENTENE CORPORATION (CNC) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $808.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2018-02-20
- CENTENE CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-12-31 was $223.00M, a 11.86% decline year-over-year.
- CENTENE CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-09-30 was $201.00M, a 34.90% increase year-over-year.
- CENTENE CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-06-30 was $252.00M, a 48.24% increase year-over-year.
- CENTENE CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2017-03-31 was $132.00M.
- CENTENE CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2017 was $808.00M, a 44.80% increase from fiscal 2016.
- CENTENE CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2016 was $558.00M, a 55.87% increase from fiscal 2015.
- CENTENE CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was $358.00M, a 37.16% increase from fiscal 2014.
- CENTENE CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was $261.00M, a 61.11% increase from fiscal 2013.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $223.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $424.00M derived: sum of 2 quarters · filed 2018-02-20 | $676.00M derived: sum of 3 quarters · filed 2018-02-20 | $808.00M 10-K · filed 2018-02-20 | ||||
| 2017-09-30 | $201.00M 10-Q · filed 2017-10-24 | $453.00M derived: sum of 2 quarters · filed 2017-10-24 | $585.00M 10-Q · filed 2017-10-24 | $838.00M derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2017-06-30 | $252.00M 10-Q · filed 2017-07-25 | $384.00M 10-Q · filed 2017-07-25 | $637.00M derived: sum of 3 quarters · filed 2018-02-20 | $786.00M derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2017-03-31 | $132.00M 10-Q · filed 2017-04-25 | $385.00M derived: sum of 2 quarters · filed 2018-02-20 | $534.00M derived: sum of 3 quarters · filed 2018-02-20 | $704.00M derived: sum of 4 quarters · filed 2018-02-20 | ||||
| 2016-12-31 | $253.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $402.00M derived: sum of 2 quarters · filed 2018-02-20 | $572.00M derived: sum of 3 quarters · filed 2018-02-20 | $558.00M 10-K · filed 2018-02-20 | ||||
| 2016-09-30 | $149.00M 10-Q · filed 2017-10-24 | $147.00M 10-Q · filed 2016-10-25 | $319.00M derived: sum of 2 quarters · filed 2017-10-24 | $305.00M 10-Q · filed 2017-10-24 | $301.00M 10-Q · filed 2016-10-25 | $417.00M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2016-06-30 | $170.00M 10-Q · filed 2017-07-25 | $169.00M 10-Q · filed 2016-07-26 | $156.00M 10-Q · filed 2017-07-25 | $154.00M 10-Q · filed 2016-07-26 | $268.00M derived: sum of 3 quarters · filed 2018-02-20 | $361.00M derived: sum of 4 quarters · filed 2018-02-20 | ||
| 2016-03-31 | -$14.00M 10-Q · filed 2017-04-25 | -$15.00M 10-Q · filed 2016-04-26 | $98.00M derived: sum of 2 quarters · filed 2018-02-20 | $191.00M derived: sum of 3 quarters · filed 2018-02-20 | $279.00M derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2015-12-31 | $112.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $205.00M derived: sum of 2 quarters · filed 2018-02-20 | $293.00M derived: sum of 3 quarters · filed 2018-02-20 | $358.00M 10-K · filed 2018-02-20 | ||||
| 2015-09-30 | $93.00M 10-Q · filed 2016-10-25 | $181.00M derived: sum of 2 quarters · filed 2016-10-25 | $246.00M 10-Q · filed 2016-10-25 | $350.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-06-30 | $88.00M 10-Q · filed 2016-07-26 | $153.00M 10-Q · filed 2016-07-26 | $257.00M derived: sum of 3 quarters · filed 2017-02-21 | $335.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-03-31 | $65.00M 10-Q · filed 2016-04-26 | $169.00M derived: sum of 2 quarters · filed 2017-02-21 | $247.00M derived: sum of 3 quarters · filed 2017-02-21 | $293.00M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2014-12-31 | $104.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $182.00M derived: sum of 2 quarters · filed 2017-02-21 | $228.00M derived: sum of 3 quarters · filed 2017-02-21 | $261.00M 10-K · filed 2017-02-21 | ||||
| 2014-09-30 | $78.00M 10-Q · filed 2015-10-27 | $77.63M 10-Q · filed 2014-10-28 | $124.00M derived: sum of 2 quarters · filed 2015-10-27 | $157.00M 10-Q · filed 2015-10-27 | $157.26M 10-Q · filed 2014-10-28 | $206.77M derived: sum of 4 quarters · filed 2016-02-22 | ||
| 2014-06-30 | $46.00M 10-Q · filed 2015-07-28 | $46.45M 10-Q · filed 2014-07-22 | $80.00M 10-Q · filed 2015-07-28 | $79.63M 10-Q · filed 2014-07-22 | $128.77M derived: sum of 3 quarters · filed 2016-02-22 | $178.64M derived: sum of 4 quarters · filed 2016-02-22 | ||
| 2014-03-31 | $33.00M 10-Q · filed 2015-04-28 | $33.18M 10-Q · filed 2014-04-22 | $82.77M derived: sum of 2 quarters · filed 2016-02-22 | $132.64M derived: sum of 3 quarters · filed 2016-02-22 | $172.45M derived: sum of 4 quarters · filed 2016-02-22 | |||
| 2013-12-31 | $49.77M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-22 | $99.64M derived: sum of 2 quarters · filed 2016-02-22 | $139.45M derived: sum of 3 quarters · filed 2016-02-22 | $162.00M 10-K · filed 2016-02-22 | $161.84M 10-K · filed 2014-02-21 | |||
| 2013-09-30 | $49.87M 10-Q · filed 2014-10-28 | $89.68M derived: sum of 2 quarters · filed 2014-10-28 | $112.23M 10-Q · filed 2014-10-28 | |||||
| 2013-06-30 | $39.82M 10-Q · filed 2014-07-22 | $62.36M 10-Q · filed 2014-07-22 | ||||||
| 2013-03-31 | $22.55M 10-Q · filed 2014-04-22 | |||||||
| 2012-12-31 | $76.00M 10-K · filed 2015-02-23 | -$11.29M 10-K · filed 2013-02-19 | ||||||
| 2011-12-31 | $38.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $66.78M derived: sum of 2 quarters · filed 2014-02-21 | $94.84M derived: sum of 3 quarters · filed 2014-02-21 | $117.66M 10-K · filed 2014-02-21 | $108.36M 10-K · filed 2012-02-21 | |||
| 2011-09-30 | $28.21M 10-Q · filed 2011-10-25 | $56.28M derived: sum of 2 quarters · filed 2011-10-25 | $79.10M 10-Q · filed 2011-10-25 | $105.48M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-06-30 | $28.06M 10-Q · filed 2011-07-26 | $50.89M 10-Q · filed 2011-07-26 | $77.27M derived: sum of 3 quarters · filed 2013-02-19 | $100.21M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-03-31 | $22.82M 10-Q · filed 2011-04-26 | $49.21M derived: sum of 2 quarters · filed 2013-02-19 | $72.15M derived: sum of 3 quarters · filed 2013-02-19 | $96.88M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2010-12-31 | $26.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $49.32M derived: sum of 2 quarters · filed 2013-02-19 | $74.05M derived: sum of 3 quarters · filed 2013-02-19 | $94.38M 10-K · filed 2013-02-19 | ||||
| 2010-09-30 | $22.94M 10-Q · filed 2011-10-25 | $47.67M derived: sum of 2 quarters · filed 2011-10-25 | $68.00M 10-Q · filed 2011-10-25 | $91.80M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | $24.73M 10-Q · filed 2011-07-26 | $45.06M 10-Q · filed 2011-07-26 | $68.86M derived: sum of 3 quarters · filed 2012-02-21 | $94.13M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $20.33M 10-Q · filed 2011-04-26 | $44.13M derived: sum of 2 quarters · filed 2012-02-21 | $69.40M derived: sum of 3 quarters · filed 2012-02-21 | $89.30M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | $23.80M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $49.07M derived: sum of 2 quarters · filed 2012-02-21 | $68.97M derived: sum of 3 quarters · filed 2012-02-21 | $88.67M 10-K · filed 2012-02-21 | ||||
| 2009-09-30 | $25.27M 10-Q · filed 2010-10-26 | $45.17M derived: sum of 2 quarters · filed 2010-10-26 | $64.87M 10-Q · filed 2010-10-26 | |||||
| 2009-06-30 | $19.90M 10-Q · filed 2010-07-27 | $39.60M 10-Q · filed 2010-07-27 | ||||||
| 2008-12-31 | $84.18M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |